Beranda › Limfoma › California › Baldwin Park
Uji klinis Limfoma di Baldwin Park, CA
21 studi untuk Limfoma mencari peserta di lokasi sekitar Baldwin Park (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma
Menerima pesertaFase 2
- City of Hope Medical Center, Duarte · 4 mi jauhnya
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Menerima pesertaFase 2
- City of Hope, Duarte · 4 mi jauhnya
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Menerima pesertaFase 1/2
- Research Site, Duarte · 4 mi jauhnya
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Menerima pesertaFase 3
- City of Hope Cancer Center, Duarte · 4 mi jauhnya
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Menerima pesertaFase 1/2
- City of Hope National Medical Center, Duarte · 4 mi jauhnya
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
Menerima pesertaFase 1/2
- City of Hope, Duarte · 4 mi jauhnya
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Menerima pesertaFase 1/2
- City of Hope, Duarte · 4 mi jauhnya
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Menerima pesertaFase 1/2
- Dren Investigational Site, Duarte · 4 mi jauhnya
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Menerima pesertaStudi observasional
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauhnya
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Menerima pesertaFase 1/2
- City of Hope, Duarte · 4 mi jauhnya
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Menerima pesertaFase 1/2
- City of Hope, Duarte · 4 mi jauhnya
A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma
Menerima pesertaFase 2
- City of Hope National Medical Center, Duarte · 4 mi jauhnya
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Menerima pesertaFase 2
- City of Hope, Duarte · 4 mi jauhnya
Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)
Menerima pesertaFase 1
- City of Hope Medical Center, Duarte · 4 mi jauhnya
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- City of Hope, Duarte · 4 mi jauhnya
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Menerima pesertaFase 1
- City of Hope Medical Foundation, Duarte · 4 mi jauhnya
Uji klinis Limfoma di kota lain
- Houston, TX34 studi
- Boston, MA33 studi
- New York City, NY33 studi
- Washington, DC23 studi
- Chicago, IL20 studi
- Durham, NC17 studi
- St. Louis, MO15 studi
- Philadelphia, PA15 studi
- Cleveland, OH14 studi
- Edison, NJ12 studi
- Atlanta, GA12 studi
- Seattle, WA12 studi
Studi lain di Baldwin Park
- Kanker Payudara45 studi
- Leukemia Mieloid Akut40 studi
- Kanker Kolorektal38 studi
- Kanker Paru Non-Sel Kecil36 studi
- Kanker (semua jenis)33 studi
- Kanker Prostat30 studi
- Kanker Metastatik30 studi
- Sindrom Mielodisplastik26 studi
- Kanker Ovarium25 studi
- Kanker Paru24 studi
- Mieloma Multipel23 studi
- Kanker Lambung22 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.